Page last updated: 2024-08-26

vinpocetine and Bone Loss, Osteoclastic

vinpocetine has been researched along with Bone Loss, Osteoclastic in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abudunaibi, M; Cheng, H; Huang, H; Li, J; Liu, H; Liu, J; Mou, Y; Qi, D; Sun, K; Tasiken, B; Zhou, C; Zhu, M	1

Other Studies

1 other study(ies) available for vinpocetine and Bone Loss, Osteoclastic

Article	Year
Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 123 Topics: Actins; Animals; Bone Resorption; Cytoprotection; Female; Gene Expression Regulation; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Osteoclasts; Osteogenesis; Ovariectomy; Proto-Oncogene Proteins c-akt; RANK Ligand; Reactive Oxygen Species; Signal Transduction; Vinca Alkaloids	2020

Article

Year

Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.

Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2020, Volume: 123

Topics: Actins; Animals; Bone Resorption; Cytoprotection; Female; Gene Expression Regulation; Male; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; NF-kappa B; Osteoclasts; Osteogenesis; Ovariectomy; Proto-Oncogene Proteins c-akt; RANK Ligand; Reactive Oxygen Species; Signal Transduction; Vinca Alkaloids

2020